1. Home
  2. LGN vs ITGR Comparison

LGN vs ITGR Comparison

Compare LGN & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGN
  • ITGR
  • Stock Information
  • Founded
  • LGN 1963
  • ITGR 1970
  • Country
  • LGN United States
  • ITGR United States
  • Employees
  • LGN N/A
  • ITGR N/A
  • Industry
  • LGN
  • ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • LGN
  • ITGR Health Care
  • Exchange
  • LGN Nasdaq
  • ITGR Nasdaq
  • Market Cap
  • LGN 3.1B
  • ITGR 2.6B
  • IPO Year
  • LGN 2025
  • ITGR 2000
  • Fundamental
  • Price
  • LGN $36.81
  • ITGR $72.76
  • Analyst Decision
  • LGN Strong Buy
  • ITGR Buy
  • Analyst Count
  • LGN 12
  • ITGR 8
  • Target Price
  • LGN $37.54
  • ITGR $94.29
  • AVG Volume (30 Days)
  • LGN 888.9K
  • ITGR 1.3M
  • Earning Date
  • LGN 11-14-2025
  • ITGR 10-23-2025
  • Dividend Yield
  • LGN N/A
  • ITGR N/A
  • EPS Growth
  • LGN N/A
  • ITGR N/A
  • EPS
  • LGN N/A
  • ITGR 2.42
  • Revenue
  • LGN $2,213,862,000.00
  • ITGR $1,831,074,000.00
  • Revenue This Year
  • LGN $13.17
  • ITGR $10.92
  • Revenue Next Year
  • LGN $11.87
  • ITGR $7.35
  • P/E Ratio
  • LGN N/A
  • ITGR $29.97
  • Revenue Growth
  • LGN 77.61
  • ITGR 9.54
  • 52 Week Low
  • LGN $26.96
  • ITGR $66.50
  • 52 Week High
  • LGN $37.90
  • ITGR $146.36
  • Technical
  • Relative Strength Index (RSI)
  • LGN N/A
  • ITGR 19.63
  • Support Level
  • LGN N/A
  • ITGR $66.50
  • Resistance Level
  • LGN N/A
  • ITGR $111.99
  • Average True Range (ATR)
  • LGN 0.00
  • ITGR 3.99
  • MACD
  • LGN 0.00
  • ITGR -3.52
  • Stochastic Oscillator
  • LGN 0.00
  • ITGR 13.76

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.

Share on Social Networks: